Skip to main content

previous disabled Page of 5
and
  1. Article

    Open Access

    Young age: an independent risk factor for disease-free survival in women with operable breast cancer

    The incidence of breast cancer in young women (age < 35) is low. The biology of the disease in this age group is poorly understood, and there are conflicting data regarding the prognosis for these women compar...

    Wonshik Han, Seok Won Kim, In Ae Park, Daehee Kang, Sung-Won Kim in BMC Cancer (2004)

  2. Article

    Open Access

    Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer

    Neogenin is expressed in cap cells that have been suggested to be mammary stem or precursor cells. Neogenin is known to play an important role in mammary morphogenesis; however its relationship to tumorigenesi...

    Jeong Eon Lee, Hee Joung Kim, Ji Yeon Bae, Seok Won Kim, Joon-Suk Park in BMC Cancer (2005)

  3. Article

    Open Access

    Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma

    Although numerous chemotherapeutic agents have been tested, the role of systemic chemotherapy for hepatocellular carcinoma (HCC) has not been clarified. New therapeutic strategies are thus needed to improve ou...

    Se Hoon Park, Yuna Lee, Sang Hoon Han, So Young Kwon, Oh Sang Kwon in BMC Cancer (2006)

  4. Article

    Open Access

    Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer

    A considerable proportion of estrogen receptor (ER)-positive breast cancer recurs despite tamoxifen treatment, which is a serious problem commonly encountered in clinical practice. We tried to find novel progn...

    Wonshik Han, Mi-Ryung Han, Jason Jongho Kang, Ji-Yeon Bae, Ji Hyun Lee in BMC Cancer (2006)

  5. Article

    Open Access

    Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

    Bcl-2 is positively regulated by hormonal receptor pathways in breast cancer. A study was conducted to assess the prognostic significances of clinico-pathologic variables and of ER, PR, p53, c-erbB2, bcl-2, or...

    Kyung-Hun Lee, Seock-Ah Im, Do-Youn Oh, Se-Hoon Lee, Eui Kyu Chie in BMC Cancer (2007)

  6. Article

    Open Access

    Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

    Prognostic factors in locally advanced breast cancer treated with neoadjuvant chemotherapy differ from those of early breast cancer. The purpose of this study was to identify the clinical significance of poten...

    Bhumsuk Keam, Seock-Ah Im, Hee-Jun Kim, Do-Youn Oh, Jee Hyun Kim, Se-Hoon Lee in BMC Cancer (2007)

  7. Article

    Open Access

    Clinicopathologic significance of HIF-1α, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer

    Hypoxia influences tumor growth by inducing angiogenesis and genetic alterations. Hypoxia-inducible factor 1α (HIF-1α), p53, and vascular endothelial growth factor (VEGF) are all important factors in the mecha...

    Sung Yong Oh, Hyuk-Chan Kwon, Sung-Hyun Kim, ** Seok Jang, Min Chan Kim in BMC Cancer (2008)

  8. Article

    Open Access

    Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

    The objective of this study was to evaluate the efficacy and toxicity of infusional 5-fluorouracil (5-FU), folinic acid and oxaliplatin (modified FOLFOX-6) in patients with advanced gastric cancer (AGC), as fi...

    Bhumsuk Keam, Seock-Ah Im, Sae-Won Han, Hye Seon Ham, Min A Kim, Do-Youn Oh in BMC Cancer (2008)

  9. Article

    Open Access

    The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

    Triple-negative (TN) breast cancer, which is defined as being negative for the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER-2), represents a sub...

    Jiyoung Rhee, Sae-Won Han, Do-Youn Oh, Jee Hyun Kim, Seock-Ah Im, Wonshik Han in BMC Cancer (2008)

  10. Article

    Open Access

    Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer

    The interleukin-6 (IL-6) pathway is one of the mechanisms that link inflammation and angiogenesis to malignancy. Because the C-reactive protein (CRP) is a representative marker for inflammation, CRP has recent...

    Do-Kyong Kim, Sung Yong Oh, Hyuk-Chan Kwon, Suee Lee, Kyung A Kwon in BMC Cancer (2009)

  11. Article

    Open Access

    Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study

    Although it is believed that fish ω-3 fatty acids may decrease breast cancer risk, epidemiological evidence has been inconclusive. This study examined the association between fish and fish ω-3 fatty acids inta...

    Jeongseon Kim, Sun-Young Lim, Aesun Shin, Mi-Kyung Sung, Jungsil Ro in BMC Cancer (2009)

  12. Article

    Open Access

    Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy

    We evaluated the hierarchical risk groups for the estimated survival of WHO grade III glioma patients using recursive partitioning analysis (RPA). To our knowledge, this is the first study to address the resul...

    Chul-Kee Park, Se-Hoon Lee, Jung Ho Han, Chae-Yong Kim, Dong-Wan Kim in BMC Cancer (2009)

  13. Article

    Open Access

    Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study

    We performed multicenter study to define clinical characteristics of noncutaneous melanomas and to establish prognostic factors patients who received curative resection.

    Hyo Song Kim, Eun Kyoung Kim, Hyun Jung Jun, Sung Yong Oh, Keon Woo Park in BMC Cancer (2010)

  14. Article

    Open Access

    Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer

    Angiogenesis is a multistep process in which many growth factors and cytokines have an essential role. Vascular endothelial growth factor (VEGF) is a potent angiogenic agent that acts as a specific mitogen for...

    Kyung A Kwon, Sung Hyun Kim, Sung Yong Oh, Suee Lee, **-Yeong Han in BMC Cancer (2010)

  15. Article

    Open Access

    Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy

    Studies about the biology, treatment pattern, and treatment outcome of metastatic/recurrent neuroendocrine tumor (NET) have been few.

    Su-Jung Kim, ** Won Kim, Sae-Won Han, Do-Youn Oh, Se-Hoon Lee, Dong-Wan Kim in BMC Cancer (2010)

  16. Article

    Open Access

    Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival

    Triple-negative breast cancers (TNBCs) and basal-like breast cancers (BLBCs) are known as poor outcome subtypes with a lack of targeted therapy. Previous studies have shown conflicting results regarding the di...

    Yoon-La Choi, Ensel Oh, Sarah Park, Yeonju Kim, Yeon-Hee Park, Kyoung Song in BMC Cancer (2010)

  17. Article

    Open Access

    The invasive lobular carcinoma as a prototype luminal A breast cancer: A retrospective cohort study

    Although the invasive lobular carcinoma (ILC) is the second most frequent histologic subtype in Western countries, its incidence is much lower in Asia, and its characteristics are less well known.

    So-Youn Jung, Junsoo Jeong, Seung-Ho Shin, Youngmee Kwon, Eun-A Kim in BMC Cancer (2010)

  18. Article

    Open Access

    Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma

    This phase II study assessed the response rate and toxicity profile of weekly paclitaxel and capecitabine in patients with metastatic or recurrent squamous cell carcinoma of the esophagus (SCCE)

    Tak Yun, Ji-Youn Han, ** Soo Lee, Hyun Lee Choi, Hyae Young Kim in BMC Cancer (2011)

  19. Article

    Open Access

    Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy

    Several inflammatory response materials could be used for prediction of prognosis of cancer patients. The neutrophil lymphocyte ratio (NLR), and the platelet lymphocyte ratio (PLR) have been introduced for pro...

    Suee Lee, Sung Yong Oh, Sung Hyun Kim, Ji Hyun Lee, Min Chan Kim, Ki Han Kim in BMC Cancer (2013)

  20. Article

    Open Access

    Prognostic effect of preoperative serum estradiol level in postmenopausal breast cancer

    The prognostic role of serum estrogen level in breast cancer patients is unclear. We investigated the prognostic importance of preoperative serum estradiol (E2) level in postmenopausal women according to their...

    Ju-Yeon Kim, Wonshik Han, Hyeong-Gon Moon, Soo Kyung Ahn, Jisun Kim in BMC Cancer (2013)

previous disabled Page of 5